Concurrent neoadjuvant chemoradiotherapy could improve survival outcomes for patients with esophageal cancer: a meta-analysis based on random clinical trials

BACKGROUND: The long-term survival benefit of concurrent neoadjuvant chemoradiotherapy in patients with resectable esophageal cancer remains controversial. In the present study, we conducted a meta-analysis to assess these effectiveness. METHODS: We searched for most relevant studies published up to...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Baoxing, Bo, Yacong, Wang, Kunlun, Liu, Yang, Tang, Xiance, Zhao, Yan, Zhao, Erjiang, Yuan, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386772/
https://www.ncbi.nlm.nih.gov/pubmed/28099899
http://dx.doi.org/10.18632/oncotarget.14669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386772/
https://www.ncbi.nlm.nih.gov/pubmed/28099899
http://dx.doi.org/10.18632/oncotarget.14669

Ejemplares similares